|
Bibliography
1. ALTUNYURT, S., DEMIR, N., and POSACI, C. A randomized
controlled trial of coil removal prior to treatment of pelvic inflammatory disease. European Journal of Obstetrics and Gynecology and Reproductive Biology 107(1): 81-84. Mar. 26, 2003.
2. ALVIOR, G.T. Pregnancy outcome with removal of intrauterine device. Obstetrics and Gynecology 41(6): 894-896. Jun. 1973.
3. ANDERSSON, K., ODLIND, V., and RYBO, G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: A randomized comparative trial. Contraception 49(1): 56-72. Jan. 1994.
4. BACKMAN, T., RAURAMO, I., HUHTALA, S., and KOSKENVUO, M. Pregnancy during the use of levonorgestrel intrauterine system. American Journal of Obstetrics and Gynecology 190(1): 50-54. Jan. 2004.
5. BADRAKUMAR, C., GOGOI, N.K., and SUNDARAM, S.K. Semen analysis after vasectomy: When and how many? BJU International 86(4): 479-481. Sep. 2000.
6. BARONE, M.A., NAZERALI, H., CORTES, M., CHEN-MOK, M., POLLACK, A.E., and SOKAL, D.C. A prospective study of time and number of ejaculations to azoospermia after vasectomy by ligation and excision. Journal of Urology 170(3): 892-896. Sep. 2003.
7. BELZER, M., YOSHIDA, E., TEJIRIAN, T., Tucker, D., and Chung, K. Advanced supply of emergency contraception for adolescent mothers increased utilization without reducing condom or primary contraception use. Journal of Adolescent Health 32(2): 122-123. Feb. 2003.
8. BERTHELSEN, J.G. [Irrigation of vas deferens during vasectomy]. Ugeskr Laeger 137(27): 1527-1529. Jul. 30, 1975. [Article in Danish]
9. BERTHELSEN, J.G. Perioperative irrigation of the vas deferens during vasectomy. Scandinavian Journal of Urology and Nephrology 10(2): 100-102. 1976.
10. CHI, I.-C. An evaluation of the levenorgestrel-releasing IUD: Its advantages and disadvantages when compared to the copper-releasing IUDs. Contraception 44(6): 573-588. Dec. 1991.
11. CHIN-QUEE, D., CUTHBERTSON, C., PIERRE-LOUIS, B., WONG, E., and TUCKER, H. Comprehensibility of instructions for what to do when pills are missed: A comparison of four instruction types. Presented at the 2004 WHO Expert Working Group Meeting To Update the Selected Practice Recommendations for Contraceptive Use, Missed Pills Subgroup, Geneva. Family Health International, Apr. 13, 2004. (34 slides)
12. CRENIN, M.D., LIPPMAN, J.S., EDER, S.E., GODWIN, A.J., and OLSON, W. The effect of extending the pill-free interval on follicular activity: Triphasic norgestimate/35 µg ethinyl estradiol versus monophasic levonorgestrel/20 µg ethinyl estradiol. Contraception 66(3): 147-152. Sep. 2002.
13. DREISHPOON, I.H. Complications of pregnancy with an intrauterine contraceptive device in situ. American Journal of Obstetrics and Gynecology 121(3): 412-413. Feb. 1, 1975.
14. ELLERSTON, C., AMBARDEKAR, S., and HEDLEY, A. Emergency contraception: Randomized comparison of advance provision and information only. Obstetrics and Gynecology 98(4): 570-575. Oct. 2001.
15. ELLERSTON, C., EVANS, M., and FERDEN, S. Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours. Obstetrics and Gynecology 101(6): 1168-1171. Jun. 2003.
16. ELOMAA, K. and LAHTEENMAKI, P. Ovulatory potential of preovulatory sized follicles during oral contraceptive treatment. Contraception 60(5): 275-279. Nov. 1999.
17. ELOMAA, K., ROLLAND, R., BROSENS, I., MOORREES, M., DEPREST, J., TUOMINEN, J., and LAHTEENMAKI, P. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation. American Journal of Obstetrics and Gynecology 179(1): 41-46. Jul. 1998.
18. FRENCH, R.S., COWAN, F.M., MANSOUR, D., HIGGINS, J.P., ROBINSON, A., PROCTER, T., MORRIS, S., and GUILLEBAUD, J. Levonorgestrel-releasing (20 µg/day) intrauterine systems (Mirena) compared with other methods of reversible contraceptives. British Journal of Obstetrics and Gynaecology 107(10): 1218-1225. Oct. 2000.
19. FULCHERI, E., DI CAPUA, E., and RAGNI, N. Pregnancy despite IUD: Adverse effects on pregnancy evolution and fetus. Contraception 68(1): 35-38. Jul. 2003.
20. GANDRUP, P., BERTHELSEN, J.G., and NIELSEN, O.S. Irrigation during vasectomy: A comparison between sterile water and the spermicide euflavine. Journal of Urology 127(1): 60-61. Jan. 1982.
21. GLASIER, A. and BAIRD, D. The effects of self-administering emergency contraception. New England Journal of Medicine 339(1): 1-4. Jul. 2, 1998.
22. GRIMES, D.A. and SCHULZ, K.F. Prophylactic antibiotics for intrauterine device insertion: A meta-analysis of the randomized controlled trials. Contraception 60(2): 57-63. Aug. 1999.
23. GU, S., SIVIN, I., and DU, M. Effectiveness of Norplant implants through seven years: A large-scale study in China. Contraception 52(2): 99-103. Aug. 1995.
24. HAMILTON, C.J. and HOOGLAND, H.J. Longitudinal ultrasonographic study of the ovarian suppressive activity of a low-dose triphasic oral contraceptive during correct and incorrect pill intake. American Journal of Obstetrics and Gynecology 161(5): 1159-1162. Nov. 1989.
25. HEDON, B., CRISTOL, P., PLAUCHUT, A., VALLON, A.M., DESACHAMPTS, F., TAILLANT, M.L., MARES, P., PIZELLE, A.M., LAFFARGUE, F., and VIALA, J. Ovarian consequences of the transient interruption of combined oral contraceptives. International Journal of Fertility 37(Suppl 3): 162-168. 1992.
26. HO, P.C. and KWAN, M.S. A prospective randomized comparison of levonorgestrel with the Yuzpe regimen in post-coital contraception. Human Reproduction 8(3): 389-392. Mar. 1993.
27. JACKSON, R.A., SCHWARZ, E.B., FREEDMAN, L., and DARNEY, P. Advance supply of emergency contraception: Effect on use and usual contraception – A randomized trial. Obstetrics and Gynecology 102(1): 8-16. Jul. 2003.
28. KILLICK, S.R. Ovarian follicles during oral contraceptive cycles: Their potential for ovulation. Fertility and Sterility 52(4): 580-582. Oct. 1989.
29. KILLICK, S.R., BANCROFT, K., OELBAUM, S., MORRIS, J., and ELSTEIN, M. Extending the duration of the pill-free interval during combined oral contraception. Advances in Contraception 6(1): 33-40. Mar. 1990.
30. KIRKINEN, P.S. Ultrasound-controlled removal of a dislocated intrauterine device in the first trimester of pregnancy: A report of 26 cases. Ultrasound in Obstetrics and Gynecology 2(5): 345-348. Sep. 1, 1992.
31. KOETSAWANG, S., RACHAWAT, D., and PIYA-ANANT, M. Outcome of pregnancy in the presence of intrauterine device. Acta Obstetricia et Gynecologica Scandinavica 56(5): 479-482. 1977.
32. KUMAR, V. and KAZA, R.M. A combination of check tug and fascial interposition with no-scalpel vasectomy. Journal of Family Planning and Reproductive Health Care 27(2): 100. Apr. 2001.
33. LANDGREN, B.M. and CSEMICZKY, G. The effect on follicular growth and luteal function of "missing the pill." A comparison between a monophasic and a triphasic combined oral contraceptive. Contraception 43(2): 149-159. Feb. 1991.
34. LANDGREN, B.M. and DICZFALUSY, E. Hormonal consequences of missing the pill during the first two days of three consecutive artificial cycles. Contraception 29(5): 437-446. May 1984.
35. LARSSON, B. and WENNERGREN, M. Investigation of a copper-intrauterine device (Cu-IUD) for possible effect on frequency and healing of pelvic inflammatory disease. Contraception 15(2): 143-149. Feb. 1977.
36. LETTERIE, G.S. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation. Contraception 57(1): 39-44. Jan. 1998.
37. LETTERIE, G.S. and CHOW, G.E. Effect of "missed" pills on oral contraceptive effectiveness. Obstetrics and Gynecology 79(6): 979-982. Jun. 1992.
38. LOVVORN, A., NERQUAYE-TETTCH, J., GLOVER, E.K., AMANKWAH-POKU, A., HAYS, M., and RAYMOND, E. Provision of emergency contraceptive pills to spermicide users in Ghana. Contraception 61(4): 287-293. Apr. 2000.
39. MERMET, J., BOLCATO, C., RUDIGOZ, R.C., and DARGENT, D. Management of pregnancies occurring with an intrauterine device in place. Revue Francaise de Gynecologie et d'Obstetrique 81(4): 233-235. Apr. 1986. [Article in French]
40. MOLLOY, B.G., COULSON, K.A., LEE, J.M., and WATTERS, J.K. "Missed pill" conception: Fact or fiction? British Medical Journal (Clinical Research Edition) 290(6480): 597-609. May 18, 1985.
41. PEARCE, I., ADEYOJU, A., BHATT, R.I., MOKETE, M., and BROWN, S.C. The effect of perioperative distal vasal lavage on subsequent semen analysis after vasectomy: A prospective randomized controlled trial. BJU International 90(3): 282-285. Aug. 2002.
42. PIAGGIO, G. and VON HERTZEN, H. Effect of delay in the administration of levonorgestrel for emergency contraception. Presented at the XVII FIGO World Congress of Gynecology and Obstetrics, Santiago, Chile, Nov. 2-7, 2003.
43. RAGAN, R.E., ROCK, R.W., and BUCK, H.W. Metoclopramide pretreatment attenuates emergency contraceptive-associated nausea. American Journal of Obstetrics and Gynecology 188(2): 330-333. Feb. 2003.
44. RAINE, T., HARPER, C., LEON, K., and DARNEY, P. Emergency contraception: Advance provision in a young, high-risk clinic population. Obstetrics and Gynecology 96(1): 1-7. Jul. 2000.
45. RAYMOND, E.G. Meclizine for prevention of nausea associated with use of emergency contraceptive pills: A randomized trial. Obstetrics and Gynecology 95(2): 271-277. Feb. 2000.
46. RODRIGUES, I., GROU, F., and JOLY, J. Effectiveness of emergency contraceptive pills between 72 and 120 hours after unprotected sexual intercourse. American Journal of Obstetrics and Gynecology 184(4): 531-537. Mar. 2001.
47. ROSS, B.S., POTTER, L.S., and ARMSTRONG, K.A. Improving patient educational literature: An understandable patient package insert for "the Pill." Journal of Obstetric, Gynecologic, and Neonatal Nursing 33(2): 192-208. Mar./Apr. 2004.
48. ROYE, C.F. Routine provision of emergency contraception to teens and subsequent condom use: A preliminary study. Journal of Adolescent Health 28(3): 165-166. Mar. 2001.
49. SHALEV, J., GREIF, M., BEN-RAFAEL, Z., ITZCHAK, Y., and SERR, D.M. Continuous sonographic monitoring of IUD extraction during pregnancy. American Journal of Roentgenology 139(3): 521-523. Sep. 1982.
50. SIVIN, I., MISHELL, D.R., DIAZ, S., BISWAS, A., ALVAREZ, F., DARNEY, P., HOLMA, P., WAN, L., BRACHE, V., KIRIWAT, O., ABDALLA, K., CAMPODONICO, I., PASQUALE, S., PAVEZ, M., and SCHECHTER, J. Prolonged effectiveness of Norplant capsule implants: A 7-year study. Contraception 61(3): 187-194. Mar. 2000.
51. SIVIN, I. and STERN, J. Health during prolonged use of levonorgestrel 20 µg/d and the copper TCu 380Ag intrauterine contraceptive devices: A multicenter study. Fertility and Sterility 61(1): 70-77. Jan. 1994.
52. SKJELDESTAD, F.E., HAMMERVOLD, R., and PETERSON, D.R. Outcomes of pregnancy with an IUD in situ: A population based case-control study. Advances in Contraception 4(4): 265-270. Dec. 1988.
53. SODERBERG, G. and LINDGREN, S. Influence of an intrauterine device on the course of an acute sapingitis. Contraception 24(2): 137-143. Aug. 1981.
54. SOKAL, D.C., IRSULA, B., HAYS, M., CHEN-MOK, M., and BARONE, M.A. Vasectomy by ligation and excision, with or without fascial interposition: A randomized controlled trial. Biomed Central Medicine 2(1): 6. Mar. 2004.
55. SPONA, J., ELSTEIN, M., FEICHTINGER, W., SULLIVAN, H., LUDICKE, F., MULLER, U., and DUSTERBERG, B. Shorter pill-free interval in combined oral contraceptives decreases follicular development. Contraception 54(2): 71-77. Aug. 1996.
56. STEVEN, J.D. and FRASER, I.S. The outcome of pregnancy after failure of an intrauterine contraceptive device. Journal of Obstetrics and Gynecology of the British Commonwealth 81(4): 282-284. Apr. 1974.
57. SULLIVAN, H., FURNISS, H., SPONA, J., and ELSTEIN, M. Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 microg) and ethinyl estradiol (15 microg) on ovarian activity. Fertility and Sterility 72(1): 115-120. Jul. 1999.
58. TASK FORCE ON POSTOVULATORY METHODS OF FERTILITY REGULATION. Randomised controlled trial of levonorgestrel versus the Yuzpe regimen of combined oral contraceptives for emergency contraception. Lancet 352(9126): 428-433. Aug. 8, 1998.
59. TATUM, H.J., SCHMIDT, F.H., and JAIN, A.K. Management and outcome of pregnancies associated with the Copper T intrauterine contraceptive device. American Journal of Obstetrics and Gynecology 126(7): 869-879. Dec. 1, 1976.
60. TEISALA, K. Removal of an intrauterine device and the treatment of acute pelvic inflammatory disease. Annals of Medicine 21(1): 63-65. Feb. 1989.
61. TRUSSELL, J. Contraceptive efficacy. In: Hatcher, R.A., Trussell, J., Stewart, F., Nelson, A., Cates, W., Guest, F., and Kowal, D. Contraceptive Technology. 18th revised ed. New York, Ardent Media, 2004.
62. VESSEY, M.P., JOHNSON, B., DOLL, R., and PETO, R. Outcome of pregnancy in women using an intrauterine device. Lancet 1(7856): 495-498. Mar. 23, 1974.
63. VON HERTZEN, H., PIAGGIO, G., DING, J., and CHEN, J. Low dose mifepristone and two regimens of levonorgestrel for emergency contraception: A WHO multicentre randomised trial. Lancet 360(9348): 1803-1810. Dec. 7, 2002.
64. WORLD HEALTH ORGANIZATION (WHO). DEPARTMENT OF REPRODUCTIVE HEALTH AND RESEARCH. Selected practice recommendations for contraceptive use. Geneva, WHO, 2002. [94] p.
65. WORLD HEALTH ORGANIZATION (WHO). DEPARTMENT OF REPRODUCTIVE HEALTH AND RESEARCH. Medical eligibility criteria for contraceptive use. 3rd ed. Geneva, WHO, 2004. 168 p. (Available: <http://www.who.int/reproductive-health/publications/MEC_3/mec.pdf>)
66. WORLD HEALTH ORGANIZATION (WHO). DEPARTMENT OF REPRODUCTIVE HEALTH AND RESEARCH. Selected practice recommendations for contraceptive use. 2nd ed. Geneva, WHO, 2004. 170 p. (Available: <http://www.who.int/reproductive-health/publications/rhr_02_7/spr.pdf>)
67. YUZPE, A.A. and LANCEE, W.J. Ethinylestradiol and dl-norgestrel as a postcoital contraceptive. Fertility and Sterility 28(9): 932-936. Sep. 1977.
68. YUZPE, A.A., THURLOW, H.J., RAMZY, I., and LEYSHON, J.I. Post coital contraception – a pilot study. Journal of Reproductive Medicine 13(2): 53-58. Aug. 1974.
Photo Credits
Photos in banner and of the OCs and Norplant Implants, David Alexander, CCP, Photoshare, a service of The INFO Project at www.photoshare.org. ECP brochures courtesy of PATH. Photo of LNG-IUD courtesy of Berlex.
Previous
INFO Reports Home | Top of Page
|
